Related references
Note: Only part of the references are listed.Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis
C. Nikolaisen et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2007)
Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis - Contrasting effects of HLA-DR3 and the shared epitope alleles
P Irigoyen et al.
ARTHRITIS AND RHEUMATISM (2005)
Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population
JSY Kwok et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2005)
HLA-DRB1 and anti-cyclic citrullinated peptide antibody production in rheumatoid arthritis
K Senkpiehl et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2005)
Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis
FA van Gaalen et al.
ARTHRITIS AND RHEUMATISM (2004)
Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis
A Suzuki et al.
NATURE GENETICS (2003)
Share Paper
